Arbutus Biopharma Corp Cash Flow Reinvestment Rate
Arbutus Biopharma Corp cash flow reinvestment rate. Arbutus Biopharma Corp (ABUS) has a Cash Flow Reinvestment Rate of 2.91x as of March 2022, reinvesting $60.06 Million (capex $75.00K plus investments $-59.98 Million) from operating cash flow of $20.62 Million. Explore Arbutus Biopharma Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Arbutus Biopharma Corp (2012–2012)
Cash flow reinvestment rate of Arbutus Biopharma Corp from 2012 to 2012. Historical reinvestment intensity for Arbutus Biopharma Corp across 1 annual periods. Explore Arbutus Biopharma Corp capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Arbutus Biopharma Corp Cash Flow Reinvestment Rate by Year (2012–2012)
Arbutus Biopharma Corp cash flow reinvestment rate by year from 2012 to 2012. Year-by-year capital reinvestment analysis for Arbutus Biopharma Corp. For the full cash flow conversion analysis, see Arbutus Biopharma Corp operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2012 | 0.00x | $14.90K | $33.27 Million | $14.90K | — |